Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SMS PHARMA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SMS PHARMA   MYLAN
EQUITY SHARE DATA
    SMS PHARMA
Mar-23
MYLAN
Dec-18
SMS PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1103,978-   
Low Rs552,190-   
Sales per share (Unadj.) Rs58.11,830.6-  
Earnings per share (Unadj.) Rs0.549.7-  
Cash flow per share (Unadj.) Rs4.3392.5-  
Dividends per share (Unadj.) Rs0.300-  
Avg Dividend yield %0.40-  
Book value per share (Unadj.) Rs54.41,980.4-  
Shares outstanding (eoy) m84.65514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.41.7 84.2%   
Avg P/E ratio x179.462.0 289.1%  
P/CF ratio (eoy) x19.37.9 246.2%  
Price / Book Value ratio x1.51.6 97.1%  
Dividend payout %65.40-   
Avg Mkt Cap Rs m6,9671,586,770 0.4%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m5500-   
Avg. sales/employee Rs Th026,910.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0730.7-  
INCOME DATA
Net Sales Rs m4,914941,863 0.5%  
Other income Rs m490-   
Total revenues Rs m4,963941,863 0.5%   
Gross profit Rs m546243,719 0.2%  
Depreciation Rs m321176,354 0.2%   
Interest Rs m22045,300 0.5%   
Profit before tax Rs m5322,065 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15-3,510 -0.4%   
Profit after tax Rs m3925,575 0.2%  
Gross profit margin %11.125.9 42.9%  
Effective tax rate %27.4-15.9 -172.2%   
Net profit margin %0.82.7 29.1%  
BALANCE SHEET DATA
Current assets Rs m4,107525,936 0.8%   
Current liabilities Rs m2,550383,465 0.7%   
Net working cap to sales %31.715.1 209.5%  
Current ratio x1.61.4 117.4%  
Inventory Days Days1884 21.1%  
Debtors Days Days1,10293 1,180.8%  
Net fixed assets Rs m4,690182,706 2.6%   
Share capital Rs m85501 16.9%   
"Free" reserves Rs m4,5210-   
Net worth Rs m4,6051,018,924 0.5%   
Long term debt Rs m1,2111,099,746 0.1%   
Total assets Rs m8,7972,733,150 0.3%  
Interest coverage x1.21.5 83.6%   
Debt to equity ratio x0.31.1 24.4%  
Sales to assets ratio x0.60.3 162.1%   
Return on assets %2.92.6 113.4%  
Return on equity %0.82.5 33.6%  
Return on capital %4.73.2 147.7%  
Exports to sales %64.40-   
Imports to sales %25.70-   
Net fx Rs m1,8950-   
CASH FLOW
From Operations Rs m225195,719 0.1%  
From Investments Rs m-297-101,165 0.3%  
From Financial Activity Rs m-320-91,177 0.4%  
Net Cashflow Rs m-3921,621 -24.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.58 Rs / USD

Compare SMS PHARMA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SMS PHARMA With: MANGALAM DRUGS  GUJ.TERC LAB  BANDARAM PHARMA PACKTECH  JAGSON PHAR  PARMAX PHARMA  



Today's Market

Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.